Jacobs Levy Equity Management
RGNX icon

Jacobs Levy Equity Management’s Regenxbio RGNX Stock Holding History

Jacobs Levy Equity Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-89,218
Closed -$936K – 1029
2024
Q3 		$936K Sell
89,218
-63,219
-41% -$771K ﹤0.01% 731
2024
Q2 		$1.78M Sell
152,437
-139,904
-48% -$2.18M 0.01% 623
2024
Q1 		$6.16M Sell
292,341
-402,843
-58% -$7.17M 0.03% 386
2023
Q4 		$12.5M Buy
695,184
+132,793
+24% +$2.34M 0.06% 276
2023
Q3 		$9.26M Buy
562,391
+1,493
+0.3% +$27.1K 0.05% 270
2023
Q2 		$11.2M Sell
560,898
-71,480
-11% -$1.38M 0.06% 262
2023
Q1 		$12M Buy
632,378
+605,255
+2,232% +$13.4M 0.07% 260
2022
Q4 		$615K Buy
27,123
+16,531
+156% +$374K ﹤0.01% 754
2022
Q3 		$280K Sell
10,592
-147,660
-93% -$4.38M ﹤0.01% 899
2022
Q2 		$3.91M Sell
158,252
-16,660
-10% -$416K 0.03% 462
2022
Q1 		$5.8M Buy
+174,912
New +$4.86M 0.04% 385
2021
Q3 		– Sell
-179,521
Closed -$6.97M – 1114
2021
Q2 		$6.97M Sell
179,521
-11,943
-6% -$427K 0.05% 372
2021
Q1 		$6.53M Buy
191,464
+164,416
+608% +$7.01M 0.05% 379
2020
Q4 		$1.23M Sell
27,048
-1,518
-5% -$53K 0.01% 672
2020
Q3 		$786K Sell
28,566
-5,261
-16% -$172K 0.01% 706
2020
Q2 		$1.25M Buy
+33,827
New +$1.26M 0.01% 627

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management's RGNX Position: Q4 2024 in Review

Jacobs Levy Equity Management sold out of Regenxbio (RGNX) in Q4 2024, closing a stake of 89,218 shares — an estimated $936K sold.

Jacobs Levy Equity Management first reported a position in RGNX in Q2 2020 and held it in 16 quarters. The position peaked at $12.5M in Q4 2023. 177 funds tracked by Wall St. Rank hold RGNX as of Q4 2024.

  • Jacobs Levy Equity Management reported no remaining Regenxbio position as of Q4 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 89,218 Regenxbio shares in Q4 2024, an estimated $936K.
  • Jacobs Levy Equity Management first reported a position in Regenxbio in Q2 2020 and held it in 16 quarters.
  • Jacobs Levy Equity Management's Regenxbio position peaked at $12.5M in Q4 2023.
  • 177 funds tracked by Wall St. Rank held Regenxbio as of Q4 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2024, filed 14 Feb 2025.